Justin M. L. Stern

Representative Matters

Cannabis and Regulatory

• Regulatory counsel to an aromatherapy and essential oils products manufacturer in relation to the company’s entry into the hemp-derived cannabidiol (CBD) market.
• Regulatory counsel to underwriter in connection with an At the Market (ATM) offering by a clinical-stage biopharmaceutical company focusing on the development of innovative cancer treatments.
• Provide state-specific medical and adult use marijuana regulatory advice to vertically integrated licensee.
• Counsel to multi-state vertically integrated marijuana operator in connection with facility licensing matters.
• Provided state-specific regulatory advice on the cultivation, manufacture, and sale of CBD products to publicly traded international cannabinoid company.
• Advised a private credit asset management firm on cannabis-related regulatory matters in connection with its provision of a revolving credit facility to support the capital needs of a publicly traded supplier to businesses in the cannabis industry.

Commercial Litigation

• Counsel to publicly traded transportation and logistics conglomerate in civil litigation involving alleged misappropriation of trade secrets.
• Obtained full dismissal of breach of contract and civil trespass claims brought against a publicly traded telecommunications service provider arising from the alleged misplacement of certain underground fiber optic cables.

Admissions

• Florida
• U.S. District Court for the Southern District of Florida
• U.S. District Court for the Middle District of Florida

Education

• University of Miami School of Law, J.D., summa cum laude, 2018
  - Order of the Coif
  - Online Editor, University of Miami Law Review
• Columbia University, B.A., magna cum laude, 2014
  - Phi Beta Kappa

Experience

• Duane Morris LLP
  - Associate, 2018-present

Professional Activities

• Federal Bar Association, 2019-present

Selected Publications

• Co-author, "Why Reformers Want Disclosure Of 3rd-Party MDL Funding," Law360, January 13, 2020
• Co-author, "Federal Minimum Age for Purchase of Tobacco Products Including E-Cigarettes Raised from 18 to 21," Duane Morris Alert, December 24, 2019
• Co-author, "With a Flurry of Warning Letters and a Consumer Update, FDA Signals Commitment to CBD Enforcement Policy," Duane Morris Alert, December 2, 2019 
• Co-author, "FDA's Bark May Be Worse Than Its Bite: Revised Guidance Permits Certain Compounding of Animal Drugs from Bulk Drug Substances," Duane Morris Alert, November 25, 2019
• Co-author, "U.S. Senators Urge Changes to Testing Requirements Under USDA Interim Final Rule for Hemp Program," Duane Morris Alert, November 22, 2019 
• Co-author, "In a Regulatory "One-Two," FDA Modifies Terms of Oversight Concerning Homeopathic Drugs," Duane Morris Alert, October 31, 2019
• Co-author, "USDA Releases Long-Awaited Federal Rules on Hemp Production, but State-by-State Regulatory Differences Remain," Duane Morris Alert, October 30, 2019
• Co-author, "In Cannabis Case, Tax Court Dissent Concludes Section 280E Is Unconstitutional," Duane Morris Alert, October 24, 2019
• Co-author, "Federal Agencies Issue Draft Guidance for Drug Master Files for First Time in 30 Years," Duane Morris Alert, October 22, 2019
• Co-author, "Discovery Ruling in District of Minnesota May Have Far-Reaching Implications for FCA Defendants," Duane Morris Alert, October 8, 2019

• Contributor, Duane Morris Cannabis Industry Blog

• Co-author, "THC Vaping Health Issues Warrant Safety Standards," Law360, September 25, 2019

• Co-author, "FTC Warning Letters and Reports of Vaping-Related Illnesses Hit Cannabis Industry," Duane Morris Alert, September 11, 2019

• Co-author, "Much of Oklahoma's $572 Million Opioid Case Likely to Be Replicated Elsewhere, But Unique Cause of Action May Not," Duane Morris Alert, August 28, 2019

• Co-author, "OTC Personal Products Manufacturer Cited by FDA for Various Regulatory Violations," Duane Morris Alert, August 27, 2019

• Co-author, "Florida’s Budding Cannabis Industry Expands With New Hemp Law," Daily Business Review, July 1, 2019

• Co-author, "New Texas Law Advances Hemp Production and Regulation," Duane Morris Alert, June 12, 2019

• Co-author, "USDA Provides Memo Clarifying Key Provisions of 2018 Farm Bill Regarding Hemp," Duane Morris Alert, May 30, 2019

• Co-author, "A Green Light for the Sunshine State - Florida Legislature Approves Sweeping Changes to Hemp, CBD Regulation," Duane Morris Alert, May 7, 2019

• Co-author, “International E-Discovery: How The 11th Circuit’s Interpretation of ‘Possession, Custody, or Control’ May Impact Multinational Corporations,” The Florida Bar Journal, January/February 2019

Selected Speaking Engagements

• Speaker, "Risks Associated With Cannabis Banking," South Florida Compliance Association, February 11, 2020
• Speaker, "Cannabis Issues in Commercial Real Estate," 6th Annual NAI Florida & Caribbean Conference, Intercontinental Miami, Miami, Florida, November 14-15, 2019
• Speaker, "Overview of New Federal Rules on Hemp Production and Q&A," Duane Morris and American Trade Association for Cannabis and Hemp, Webinar, November 6, 2019

• Presenter, "Cannabis 204: The Roundup of State Cannabis Legislation," Duane Morris Cannabis Webinar Series, August 20, 2019

• Presenter, "Possession, Custody, or Control Under Fed. R. Civ. P. 34: Implications of Interpretation," Miami, FL, April 12, 2019